[Morvan's fibrillary chorea following chrysotherapy].
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002819:Chorea / Q000139:chemically induced*; D004112:Dimercaprol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007866:Leg; D008667:Metalloproteins / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009207:Myoclonus / Q000139:chemically induced*; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds; D013577:Syndrome
D008667:Metalloproteins; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds; D004112:Dimercaprol; C013394:aurotioprol
Chorée fibrillaire de Morvan après chrysothérapie.